Search

Your search keyword '"Pan, Lanlan"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Pan, Lanlan" Remove constraint Author: "Pan, Lanlan"
125 results on '"Pan, Lanlan"'

Search Results

1. Measuring the Resolution Resiliency of Second-Level Domain Name

3. Combined Aerobic Fermentation of Maricultural and Agricultural Solid Waste: Physicochemical Property and Bacterial Community Structure.

4. Improving Privacy for GeoIP DNS Traffic

5. EPT: EDNS Privacy Tunnel for DNS

8. AWCR: Adaptive and Weighted Collaborative Representations for Face Super-Resolution with Context Residual-Learning

9. Efficacy and safety of XELOX combined with anlotinib and penpulimab vs XELOX as an adjuvant therapy for ctDNA-positive gastric and gastroesophageal junction adenocarcinoma: a protocol for a randomized, controlled, multicenter phase II clinical trial (EXPLORING study)

13. PCL–CNT Nanocomposites

15. Efficacy and safety of XELOX combined with anlotinib and penpulimab vs XELOX as adjuvant therapy in ctDNA-positive gastric and esophagogastric junction adenocarcinoma: A protocol for a randomized, controlled, multicenter phase II clinical trial—EXPLORING study.

16. Camrelizumab plus low-dose apatinib and SOX in the first-line treatment of advanced gastric/gastroesophageal junction (G/GEJ) adenocarcinoma: A single-arm, dose escalation and expansion study (SPACE study).

17. A single-arm, open-label, phase II study investigating anti-HER2 ADC plus anti-PD-1 antibody in patients with unresectable locally advanced or metastatic BTC with HER2 overexpression.

18. Tislelizumab combined with anlotinib and chemotherapy (XELOX) in the treatment of advanced gastric carcinoma: Preliminary results of a single-arm, open-label phase I/IIa trial (TALENT study).

21. Low-dose apatinib combined with camrelizumab and the SOX regimen in the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma (SPACE-neo): a protocol for an open-label, single-arm, clinical trial

23. Simulation of English part-of-speech recognition based on machine learning prediction algorithm

24. Camrelizumab plus low-dose apatinib and SOX in the first-line treatment of advanced gastric/gastroesophageal junction (G/GEJ) adenocarcinoma: A single-arm, dose-escalation and expansion study.

28. Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

30. Optimisation of overhead crane path based on RRT-A* fusion improvement algorithm

37. A Defined Combination of Four Active Principles From the Danhong Injection Is Necessary and Sufficient to Accelerate EPC-Mediated Vascular Repair and Local Angiogenesis

41. Face Super-Resolution by Deep Collaborative Representation

45. Selected Phytoestrogens Distinguish Roles of ERα Transactivation and Ligand Binding for Anti-Inflammatory Activity

Catalog

Books, media, physical & digital resources